Company name: Releaf Europe
Description: Developer of cannabis-based medicines intended to provide medical cannabis care. The company offers CBD products for medical use through licensed pharmacies, providing the customers with self care products based on the hemp plant.
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company raised venture funding in the form of convertible debt from Cresco Capital Partners on an undisclosed date.
Number of active investors:
Profile last updated: 12-Apr-2019
Last known valuation:
Last known valuation date: